Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Mapping complex cognitive problems across psychiatric and neurological conditions

Official title: Characterization of High-level Cognitive Impairments in Patients With Neuropsychiatric Disorders

Run by Centre Hospitalier St Anne · NCT07295652 · Data updated 2026-11-12

This project will test a set of cognitive tests and optional brain recordings in adults with psychiatric or neurological disorders and healthy volunteers to map high-level thinking problems and how they change over time.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment600 (estimated)
SponsorCentre Hospitalier St Anne
Academic / other
Locations3 sites (Paris and 2 other locations)
StatusRecruiting
StartedMarch 12, 2024
Main results expectedMarch 2039
Study endsMarch 2039
Registry record updatedDecember 19, 2025
Trial IDNCT07295652 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 with a diagnosed psychiatric disorder (e.g., schizophrenia, bipolar, depressive, ASD, OCD) or a diagnosed neurological disorder (e.g., neurodegenerative disease, focal lesion, epilepsy) who can give informed consent and attend in-person visits are ideal candidates.

Probably not a fit

People unable to complete cognitive testing due to severe motor or sensory impairment, those with active substance use disorder (except tobacco), or with unstable acute medical or psychiatric conditions are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The project will build a multidimensional, transdiagnostic atlas of high-level cognitive impairments by testing adults with a range of psychiatric and neurological diagnoses alongside healthy volunteers. Cognitive testing will be combined with optional MRI, EEG, and MEG to link behavioral profiles with brain measures. Tests will be iteratively refined to be shorter, more ergonomic, and suitable for digital platforms based on participant feedback and interim analyses. Repeated evaluations are planned to track changes with clinical course and routine treatments.

Why it matters

Potential benefit: If successful, the work could produce shorter, more usable digital tests and brain markers that help clinicians track cognitive problems and tailor care.

How similar studies have gone: Previous studies have characterized domain-specific cognitive deficits and linked them to brain measures, but a large transdiagnostic, high-level cognitive atlas combined with adaptive digital tests and multimodal neuroimaging remains relatively novel and not yet established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

For patients:

* Aged over 18 years
* Diagnosed with a psychiatric disorder according to ICD-10 by a psychiatrist (F10-F98) or diagnosed with a neurological disorder according to ICD-10 by a neurologist (G00-G99)
* Provided written informed consent
* Affiliated with a social security scheme

For healthy volunteers:

* Aged over 18 years
* Provided written informed consent
* Affiliated with a social security scheme

Exclusion Criteria:

For healthy volunteers:

* Current diagnosis of a psychiatric disorder according to ICD-10 (F20-F98) or current prescription of a psychotropic medication, or diagnosis of a neurological disorder according to ICD-10 (G00-G99)
* History of depression (F32)
* Substance use disorder (excluding tobacco)
* Neurological history (e.g., stroke, coma, epilepsy, neuroinflammatory or neurodegenerative disease) or identified cognitive disorder
* Inability to complete cognitive testing (e.g., due to motor or sensory impairment)

For participants undergoing MRI (without contrast agent):

* Presence of MRI contraindications: non-MRI-compatible pacemaker, heart valve, implant, or metallic foreign body
* Pregnancy at the time of MRI

Where it's running

  • Departement of Adult Psychiatry, GH Pitié Salpétrière
    Paris, France
    Recruiting
  • Groupe hospitalo-universitaire Paris Psychiatrie et Neurosciences
    Paris, France
    Recruiting
  • Hôpital Fondation Adolphe de Rothschild
    Paris, France
    Not yet recruiting

Study contacts

  • Principal investigator: Pierre BOURDILLON, Dr — Hôpital Fondation Adolphe de Rothschild
  • Study coordinator: Jacob DHOTE, Dr
  • Email: j.dhote@ghu-paris.fr
  • Phone: +33 145658177

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.